SHG:688366 - Shanghai Haohai Biological Technology Co Ltd

Shanghai Haohai Biological Tec
Sector: Health Care, Industry: Biotechnology

Add to Watchlist

•  Default
• New Watchlist

   

Yahoo Finance

• Summary
• Financials
• Dividend
• Prices
• Posts
• User
• Alerts

Balance Sheet Cash Flow Income Statement Key Ratios Personalized

Show %	2014 Q2	2014 Q4	2015 Q2	2015 Q4	2016 Q2	2016 Q4	2017 Q2	2017 Q4	2018 Q2	2018 Q4	2019 Q2	2019 Q4	2020 Q2	2020 Q4	2021 Q2	2021 Q4	2022 Q2	2022 Q3	2022 Q4	2023 Q2	2023 Q3	2023 Q4	Graph
Total Revenue	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	1.68B 26.6%	1.75B 4.4%	1.86B 6.3%	626.29M -66.3%	2.1B 235.9%	2.45B 16.6%	2.5B 2.0%	2.63B 5.3%
Cost of Revenue	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	437.74M 31.1%	490.37M 12.0%	563.06M 14.8%	184.37M -67.3%	656.51M 256.1%	746.32M 13.7%	744.56M -0.2%	781.4M 4.9%
Gross Profit	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	1.24B 25.1%	1.26B 1.7%	1.3B 3.0%	441.92M -65.9%	1.45B 227.4%	1.71B 17.9%	1.76B 3.0%	1.85B 5.4%
Total Expenses	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	1.29B 7.7%	1.52B 17.9%	1.76B 15.4%	561.18M -68.0%	1.88B 235.6%	2.09B 11.0%	2.11B 1.1%	2.2B 3.9%
Operating Expense	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	853.79M -1.3%	1.03B 20.9%	1.19B 15.6%	376.81M -68.4%	1.23B 225.6%	1.34B 9.6%	1.37B 1.8%	1.42B 3.4%
Operating Income	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	385.16M 207.3%	227.59M -40.9%	104.2M -54.2%	65.11M -37.5%	220.17M 238.1%	361.89M 64.4%	389.27M 7.6%	438.38M 12.6%
Net Income (Cont Operations)	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	-	382.65M -	-	-	235.73M -	-	-	508.26M -
Net Income	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	433.57M 88.4%	352.23M -18.8%	192.24M -45.4%	90.72M -52.8%	180.47M 98.9%	314.68M 74.4%	345.52M 9.8%	416.12M 20.4%
Basic EPS	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	2.46 89.2%	2 -18.7%	1.1 -45.0%	0.52 -52.7%	1.04 100%	1.83 76.0%	2.02 10.4%	2.44 20.8%
Diluted EPS	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	2.46 89.2%	2 -18.7%	1.1 -45.0%	0.52 -52.7%	1.04 100%	1.83 76.0%	2.02 10.4%	2.44 20.8%